Table 1. Peak KAM, KAM impulse, and peak KFM at baseline in knees without and with semiquantitative cartilage damage progression and bone marrow lesion progression, mean (SD) (n = 391 knees from 204 persons).

		Cartilage damage progression at 2-year follow-up			Bone marrow lesion progression at 2-year follow-up
		Medial tibiofemoral compartment 61/391 (15.6%)#	Medial femoral surface 48/391 (12.3%)	Medial tibial surface 29/391 (7.4%)	Medial tibiofemoral compartment 87/391 (22.3%)	Medial femoral surface 53/391 (13.6%)	Medial tibial surface 48/391 (12.3%)
		Peak KAM (% body wt*ht)	Knees without progression	1.66 (0.87)	1.67 (0.86)	1.65 (0.86)	1.59 (0.86)	1.65 (0.87)	1.60 (0.85)
Knees with progression	1.70 (0.77)		1.68 (0.81)	1.83 (0.76)	1.92 (0.77)	1.77 (0.73)	2.15 (0.71)
KAM impulse (s*% body wt*ht)	Knees without progression	0.60 (0.43)	0.60 (0.43)	0.59 (0.43)	0.55 (0.42)	0.59 (0.44)	0.56 (0.42)
	Knees with progression	0.64 (0.50)	0.64 (0.51)	0.73 (0.51)	0.79 (0.47)	0.70 (0.43)	0.92 (0.45)
Peak KFM (% body wt*ht)	Knees without progression	2.11 (0.86)	2.10 (0.86)	2.10 (0.86)	2.08 (0.89)	2.09 (0.88)	2.10 (0.87)
	Knees with progression	1.98 (0.80)	2.01 (0.81)	1.98 (0.84)	2.13 (0.74)	2.15 (0.71)	2.08 (0.78)

^#Percentage of knees (%) with 2-year progression